A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial – medRxiv   Commentary on Twitter 6-month follow-up of people aged 60+ in early trials of Sinovac's CoronaVac in China. Authors conclude antibodies dropped too far, but […]

The post [Preprint] Phase 1/2 RCT: A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac. appeared first on Links Medicus.